Skip to content
Back to MXCT

Maxcyte, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
1
Purchases
0
Sales
1
Purchase value
$0.00
Sale value
$8.27K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Douglas J SwirskyCHIEF FINANCIAL OFFICER
4
Filed Mar 19, 2026Period of report Mar 17, 20260000905148-26-001397
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 17, 2026
Common StockF1F210,142$0.815$8.27K151,669Direct
Filing footnotes · 2
  1. F1These shares were sold to cover tax withholding due upon vesting of previously granted restricted stock units ("RSUs"). Such "sale to cover" was automatically effected to satisfy tax withholding obligations and does not represent a discretionary trade by the Reporting Person.
  2. F2The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.783 to $0.825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.